Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 45.6B | 52.4B | 40.4B | 33.0B |
| Cost of revenue | 27.0B | 27.3B | 26.5B | 23.0B |
| Gross profit | 18.5B | 25.1B | 13.8B | 10.0B |
| Operating expense | ||||
| Research & development | 643.7M | 348.6M | 452.7M | 547.2M |
| Selling general and admin | 9.8B | 10.5B | 7.9B | 6.9B |
| Other operating expenses | 1.5B | -2.2B | 1.1B | 486.8M |
| Operating income | 7.4B | 18.6B | 5.2B | 2.5B |
| Non operating interest income | ||||
| Income | 2.5B | 627.1M | 216.6M | 1.5B |
| Expense | 7.8B | -11.5B | 6.6B | 8.1B |
| Other income expense | — | — | — | — |
| Pretax income | 8.6B | 15.8B | 3.3B | 1.7B |
| Tax provision | 3.5B | 11.2B | 2.2B | 319.5M |
| Net income | 5.1B | 4.5B | 1.1B | 1.4B |
| Basic EPS | 1.5 | — | 0.3 | 0.4 |
| Diluted EPS | 1.5 | — | 0.3 | 0.4 |
| Basic average shares | 3.5B | — | 3.5B | 3.5B |
| Diluted average shares | 3.5B | — | 3.5B | 3.5B |
| EBITDA | 26.3B | 8.0B | 22.8B | 20.2B |
| Net income from continuing op. | 5.1B | 4.5B | 1.4B | -986.4M |
| Minority interests | — | — | — | — |
| Preferred stock dividends | 0 | 0 | 0 | 0 |